Scholarly Index
Rosario Menéndez
Instituto de Investigación Sanitaria La Fe; 15,348 total citations; 430 total publications; best world rank #72
Instituto de Investigación Sanitaria La Fe
15,348Total citations
430Total publications
66H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pneumonia and Respiratory Infections | Lifetime | 115 | ES 7 | 99.47 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 150 | ES 7 | 98.97 |
| Nosocomial Infections in ICU | Lifetime | 72 | ES 7 | 99.23 |
| Emergency and Acute Care Studies | Lifetime | 178 | ES 3 | 98.76 |
| Respiratory viral infections research | Lifetime | 385 | ES 6 | 98.50 |
| COVID-19 Clinical Research Studies | Lifetime | 905 | ES 22 | 97.02 |
| Sepsis Diagnosis and Treatment | Lifetime | 441 | ES 8 | 98.06 |
| Long-Term Effects of COVID-19 | Lifetime | 592 | ES 29 | 95.89 |
| Cystic Fibrosis Research Advances | Lifetime | 429 | ES 12 | 96.68 |
| Actinomycetales infections and treatment | Lifetime | 492 | ES 17 | 80.35 |
| COVID-19 Clinical Research Studies | 2021-2025 | 449 | ES 13 | 97.95 |
| Long-Term Effects of COVID-19 | 2021-2025 | 297 | ES 20 | 96.87 |
| Pneumonia and Respiratory Infections | 2021-2025 | 208 | ES 12 | 95.41 |
| Respiratory viral infections research | 2021-2025 | 708 | ES 36 | 90.45 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 749 | ES 19 | 90.15 |
| Cystic Fibrosis Research Advances | 2021-2025 | 386 | ES 18 | 91.02 |
| Inflammation biomarkers and pathways | 2021-2025 | 628 | ES 18 | 23.34 |